Blueberries Medical Corp. (BBRRF) Stock Price & Analysis
Blueberries Medical Corp. (BBRRF) — price $0.00885 (0.00%), as of the Nov 18, 2026 trading session; market cap $5.13M.
Educational signal · not a buy or sell recommendation · How to read this
Blueberries Medical Corp. · BBRRF
Blueberries Medical Corp. is a Colombia-based company focused on the cultivation, production, and supply of medicinal cannabis. It operates in the emerging Latin American cannabis market, offering medicinal-grade cannabis oil extracts.
Price as of Nov 18, 2026
Key Statistics
Not scored: MoonshotScore covers actively traded US operating companies, not funds, preferred shares, warrants or thinly traded stocks.
Thousands of the 20,000+ US stocks here carry a MoonshotScore.
Scored companies in the same industry:
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $0.00885 | |
| Change on the day | 0.00% | |
| 52-week range | $0.0038 – $0.015 | |
| Market capitalisation | $5.13M | — |
| Shares traded on the day | 721.0K |
Price & events
Other perspectives
Council score for Blueberries Medical (BBRRF): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
2 lenses, 2 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Blueberries Medical (BBRRF), and what does it report?
Short answer
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Blueberries Medical Corp. (BBRRF) is the company analyzed here. It employs 5 people and is led by Facundo Garreton. In Q2 FY2026 it reported revenue of C$35,120 and net income of -C$206,534. The market values it at $5.13M.
What do the latest results show for Blueberries Medical (BBRRF)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of C$35,120.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | C$35,120 | -C$206,534 | -C$0.0004 (diluted) |
| Q1 FY2026 | C$42,846 | -C$168,896 | -C$0.0003 (diluted) |
| Q4 FY2025 | C$163,448 | -C$497,808 | -C$0.0015 (diluted) |
| Q3 FY2025 | C$35,610 | -C$189,348 | C$0.00 (diluted) |
What are the financial strengths and risks for Blueberries Medical (BBRRF)?
Short answer · as of
The distress and quality screens read Piotroski F 3. Trailing ratios: current ratio 0.44 · earnings yield -21.6% · free-cash-flow yield -12.3%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held BBRRF in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported BBRRF in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Investor Questions: BBRRF Stock
These answers are editorial: 1 of these 1 answer is drawn from the BBRRF research dossier (written Mar 16, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What do analysts say about BBRRF stock?
As an OTC-listed company with a small market capitalization, Blueberries Medical Corp. (BBRRF) may not be widely covered by analysts.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 13 figures on this page — 7 from Financial Modeling Prep (FMP) and 6 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com